Arno is a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics. The company has exclusive worldwide rights to three innovative clinical stage compounds with unique mechanisms of action that have the potential to be first in class products for the treatment of various forms of cancer, including both hematologic malignancies and solid tumors, and other life threatening diseases. The lead compound, onapristone, is an oral, anti progestin currently in a Phase I/II clinical trial for patients with castration resistant prostate cancer.
Quote | Arno Therapeutics Inc (OTCMKTS:ARNI)
Last: | $5.8e-05 |
---|---|
Change Percent: | 0.0% |
Open: | $5.8e-05 |
Close: | $5.8e-05 |
High: | $5.8e-05 |
Low: | $5.8e-05 |
Volume: | 350 |
Last Trade Date Time: | 03/01/2024 03:00:00 am |
News | Arno Therapeutics Inc (OTCMKTS:ARNI)
Message Board Posts | Arno Therapeutics Inc (OTCMKTS:ARNI)
Subject | By | Source | When |
---|---|---|---|
what's the deal with this stock/company? | Chrisny73 | investorshub | 02/27/2020 6:50:54 PM |
Agreed. Its just weird that its not in | Stoxinc | investorshub | 08/07/2018 2:56:52 AM |
Me too but this company is practically defunct. | TheWhigs | investorshub | 08/06/2018 3:21:42 PM |
Was looking interesting there for a couple | Stoxinc | investorshub | 08/03/2018 1:39:06 AM |
False signal....LOL! | TheWhigs | investorshub | 08/02/2018 7:41:39 PM |